Location: Palo Alto, CA
CIK: 0001306923 · Show all filings
Period: Q4 2018 (← Previous) (Next →)
Filing Date: Feb 14, 2019
Total Value: $1.878B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| — | ABIOMED INC | 689,550 | $224M | 11.9% | $325.04 | $32.04 | — | COM | 003654100 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 2,559,733 | $218M | 11.6% | $85.15 * | $79.79 | +19.2% | COM | 09061G101 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 1,632,025 | $178M | 9.5% | $108.90 * | $88.73 | +30.7% | COM | 91307C102 |
| STAA | STAAR SURGICAL CO | 4,147,988 | $132M | 7.0% | $31.91 * | $12.68 | +207.3% | COM PAR $0.01 | 852312305 |
| — | ALEXION PHARMACEUTICALS INC | 1,204,328 | $117M | 6.2% | $97.36 | $121.26 | — | COM | 015351109 |
| VNDA | VANDA PHARMACEUTICALS INC | 4,155,670 | $109M | 5.8% | $26.13 * | $8.70 | +170.2% | COM | 921659108 |
| INSM | INSMED INC | 7,653,617 | $100M | 5.3% | $13.12 * | $16.83 | -5.2% | COM PAR $.01 | 457669307 |
| — | CLOVIS ONCOLOGY INC | 5,239,304 | $94.1M | 5.0% | $17.96 | $51.30 | — | COM | 189464100 |
| — | SAGE THERAPEUTICS INC | 850,977 | $81.52M | 4.3% | $95.79 | $48.62 | — | COM | 78667J108 |
| — | WRIGHT MED GROUP N V | 2,771,394 | $75.44M | 4.0% | $27.22 | $23.42 | — | ORD SHS 0.03 PAR | N96617118 |
| — | IMMUNOMEDICS INC | 5,186,255 | $74.01M | 3.9% | $14.27 | $12.01 | — | COM | 452907108 |
| FOLD | AMICUS THERAPEUTICS INC | 7,401,321 | $70.91M | 3.8% | $9.58 * | $7.28 | +51.0% | COM | 03152W109 |
| — | AMAG PHARMACEUTICALS INC | 3,380,506 | $51.35M | 2.7% | $15.19 | $29.26 | — | COM | 00163U106 |
| — | KARYOPHARM THERAPEUTICS INC | 4,685,352 | $43.9M | 2.3% | $9.37 | $18.85 | — | COM | 48576U106 |
| — | EPIZYME INC | 6,935,074 | $42.72M | 2.3% | $6.16 | $15.12 | — | COM | 29428V104 |
| — | CELGENE CORP | 532,667 | $34.14M | 1.8% | $64.09 | $89.02 | — | COM | 151020104 |
| — | AIMMUNE THERAPEUTICS INC | 1,387,589 | $33.19M | 1.8% | $23.92 | $23.79 | — | COM | 00900T107 |
| ALGN | ALIGN TECHNOLOGY INC | 156,823 | $32.84M | 1.7% | $209.43 * | $107.51 | +135.0% | COM | 016255101 |
| ACAD | ACADIA PHARMACEUTICALS INC | 2,026,063 | $32.76M | 1.7% | $16.17 * | $27.84 | -30.2% | COM | 004225108 |
| PBYI | PUMA BIOTECHNOLOGY INC | 1,159,900 | $23.6M | 1.3% | $20.35 * | $30.01 | 0.0% | COM | 74587V107 |
| — | MOMENTA PHARMACEUTICALS INC | 1,841,613 | $20.33M | 1.1% | $11.04 | $14.12 | — | COM | 60877T100 |
| EXAS | EXACT SCIENCES CORP | 314,889 | $19.87M | 1.1% | $63.10 * | $13.61 | +404.1% | COM | 30063P105 |
| — | ALDER BIOPHARMACEUTICALS INC | 1,861,630 | $19.08M | 1.0% | $10.25 | $11.48 | — | COM | 014339105 |
| PRTA | PROTHENA CORP PLC | 1,108,510 | $11.42M | 0.6% | $10.30 * | $32.98 | -64.0% | SHS | G72800108 |
| GILD | GILEAD SCIENCES INC | 175,900 | $11M | 0.6% | $62.55 * | $62.02 | -14.5% | COM | 375558103 |
| — | RIGEL PHARMACEUTICALS INC | 3,985,945 | $9.168M | 0.5% | $2.30 | $3.40 | — | COM NEW | 766559603 |
| — | SHIRE PLC | 47,938 | $8.343M | 0.4% | $174.04 | $197.13 | — | SPONSORED ADR | 82481R106 |
| — | DICERNA PHARMACEUTICALS INC | 500,913 | $5.355M | 0.3% | $10.69 | $5.39 | — | COM | 253031108 |
| — | ALIMERA SCIENCES INC | 3,013,793 | $2.164M | 0.1% | $0.72 | $4.88 | — | COM | 016259103 |
| — | ZOGENIX INC | 29,500 | $1.076M | 0.1% | $36.47 | $13.36 | — | COM NEW | 98978L204 |
| CYTK | CYTOKINETICS INC | 123,686 | $782K | 0.0% | $6.32 * | $6.71 | +9.3% | COM NEW | 23282W605 |
| — | SUNESIS PHARMACEUTICALS INC | 1,162,473 | $483K | 0.0% | $0.42 | $4.37 | — | COM PAR | 867328700 |
| — | IDERA PHARMACEUTICALS INC | 77,044 | $213K | 0.0% | $2.76 | $8.90 | — | COM PAR | 45168K405 |
| — | SOPHIRIS BIO INC | 247,000 | $205K | 0.0% | $0.83 | $2.60 | — | COM NEW | 83578Q209 |
| — | MELINTA THERAPEUTICS INC | 50,689 | $40,000 | 0.0% | $0.79 | $15.80 | — | COM | 58549G100 |
| — | HISTOGENICS CORP | 302,922 | $27,000 | 0.0% | $0.09 | $11.00 | — | COM | 43358V109 |